Amgen has won FDA approval for a new device that allows for monthly dosing of its cholesterol-busting drug Repatha. Is it a game-changing innovation in its fight against Regeneron Pharmaceuticals and Sanofi?
Medivation is the drug industry's hottest takeover target, and it is doing everything it can to milk that.
The company has received at least two bids from Sanofi that Medivation has rejected, and earlier this week said it entered into...
Oops! Unable to complete your request. Please refresh your browser.